human protein is also frequently referred to as HER2 (human epidermal growth factor receptor 2) or CD340 (cluster of differentiation 340). HER2 is a member
monoclonal antibody against HER2; its epitope is the domain where HER2 binds to another HER2protein. The two mAbs together prevent HER2 from functioning. Pertuzumab
cancer treatment Herceptin, a monoclonal antibody, that targets the HER2protein, which is impacted in aggressive breast cancers. He served as Physician-in-Chief
receptor signal processes by binding to the ATP-binding pocket of the EGFR/HER2protein kinase domain, preventing self-phosphorylation and subsequent activation
breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy